Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
In light of their findings, Dana-Farber Cancer Institute researchers urge patients who delayed screening during the initial COVID-19 surge to contact their provider and reschedule.
Massachusetts General Hospital designed its pilot program to serve dual-eligible women who face significant barriers to completing their exams in outpatient settings.
Those who underwent neuroimaging and were diagnosed with stroke were also twice as likely to die compared to age-matched controls, according to new research published in Neurology.